profit from every $100 of sales.
$0$100
Milestone Scientific
$0.31+5.86% today
-19.1% in 1 year
1-year low $0.251-year high $0.55
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Milestone Scientific sold, what it kept, and what it did with the cash.
Sales went from $8.81 million in 2022 to $8.97 million in 2025, with -$5.72 million of profit last year.
SalesProfit
Milestone Scientific vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Milestone Scientific | No profit yet | ||
 ResMed | 22.1× · Fair price | ||
 West Pharmaceutical Services | 58.8× · Expensive | ||
 Hologic | 30.0× · Fair price | ||
 Baxter International | No profit yet |
AI analysis
An AI analyst reads Milestone Scientific's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9 | 10 | 9 | 9 | |
| 5 | 7 | 6 | 6 | |
| -9 | -7 | -7 | -6 | |
| -9 | -7 | -7 | -6 | |
| -9 | -7 | -5 | -6 | |
| -0.12 | -0.10 | -0.06 | -0.07 | |
| 55.7% | 69.1% | 74.6% | 71.4% | |
| -100.2% | -72.3% | -78.3% | -63.5% | |
| -98.9% | -70.5% | -54.6% | -63.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 14 | 11 | 10 | 8 |
| Cash | 9 | 3 | 3 | 1 |
| Total debt | 0 | 0 | 0 | 1 |
| Total liabilities | 4 | 3 | 4 | 5 |
| 10 | 8 | 6 | 3 | |
| 71 | 73 | 80 | 82 | |
| -65.0% | -66.8% | -86.4% | -117.4% | |
| -85.1% | -86.5% | -80.8% | -203.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -6 | -5 | -3 | -3 | |
| 0 | 0 | 0 | 0 | |
| -6 | -5 | -3 | -3 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 2 | 2 | 2 | 2 |
Valuation
- –
- –
- –
- 13.3×
- 3.1×
- –
- –
- -10.5%
- -20.6%
- 0.0%
Profitability
- 71.4%
- -63.5%
- -63.8%
- -62.6%
- -148.6%
- -85.9%
- -173.9%
- -73.3%
- -155.0%
- 5.0%
Growth
- +0.6%
- –
- −0.1%
- –
- +4.5%
Financial health
- -0.0×
- 0.36
- 13.1%
- -594.9×
- 1.81
- 0.89
- 1.15
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 6%of 872
Bottom 17%of 868
Bottom 11%of 986
What analysts expect
- Average price target
- $4.00
- Range
- $4.00 – $4.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.01 | -0.02 | +33.3% |
| Mar 31, 2026 | -0.02 | -0.02 | −33.3% |
| Nov 13, 2025 | -0.01 | -0.02 | +33.3% |
| Aug 14, 2025 | -0.02 | -0.01 | −100.0% |
| Apr 15, 2025 | -0.03 | -0.01 | −200.0% |
| Mar 28, 2025 | -0.03 | -0.01 | −155.1% |
| Nov 14, 2024 | -0.02 | -0.01 | −100.0% |
| Aug 14, 2024 | -0.02 | -0.01 | −100.0% |
News
MP Materials Clears GM Magnet Milestone, Targets Apple as Next CustomerYahoo Finance · Nov 11, 2026The S&P 500 Is Chasing a Milestone That's Only Been Hit 9 Times Since 1926. Here’s What History Says Comes Next.Yahoo Finance · Nov 1, 2026Elon Musk Became the First Person Ever Confirmed With a Net Worth Above $1 Trillion in June 2026. Here's Why That Milestone Still Matters for Tesla and SpaceX Shareholders.Yahoo Finance · Oct 25, 2026Investing, not homeownership, is the No. 1 milestone that makes Gen Z renters feel successfulMarketWatch · Oct 17, 2026Anthropic Just Became the First Company in History To Reach This Milestone. Here's What It Means for AI StocksYahoo Finance · Oct 15, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
36No pass
Benjamin Graham
28No pass
Philip Fisher
33No pass
Peter Lynch
26No pass
Joel Greenblatt
0No pass
Charlie Munger
29No pass
Terry Smith
25No pass
Questions about Milestone Scientific
Is Milestone Scientific a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Milestone Scientific AI analysis
What does Milestone Scientific do?
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. It is in Medical - Instruments & Supplies.
Does Milestone Scientific pay a dividend?
No. Milestone Scientific does not pay a dividend at the moment.
Is Milestone Scientific stock halal?
Yes. Milestone Scientific passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has Milestone Scientific stock done over the past year?
Down 19.1% over the past twelve months, to $0.31. It traded between $0.25 and $0.55 and is 44.2% below its high.
Who are Milestone Scientific's competitors?
The largest listed companies in the same industry are ResMed, West Pharmaceutical Services, Hologic and Baxter International. The peers table on this page compares their profit, growth and price with Milestone Scientific's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.